Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients

[1] Hoover-Plow J(2013)Lipoprotein(a) metabolism: potential sites for therapeutic targets Metabolism 62 479-491

[2] Huang M(2018)The identification of Core gene expression signature in hepatocellular carcinoma Oxidative Med Cell Longev 2018 3478305-262

[3] Li N(2018)Management of chronic hepatitis B during pregnancy Gastroenterol Rep (Oxf) 6 257-1067

[4] Li L(2015)Physiology and pathophysiology of liver lipid metabolism Expert Rev Gastroenterol Hepatol 9 1055-2333

[5] Chen Y(2011)Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association Circulation 123 2292-2751

[6] Aslam A(2013)Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans J Clin Invest 123 2742-534

[7] Campoverde Reyes KJ(2003)Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice Arterioscler Thromb Vasc Biol 23 529-359

[8] Malladi VR(2005)The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins Clin Chem 51 351-125

[9] Ishtiaq R(2015)Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease Curr Opin Endocrinol Diabetes Obes 22 119-119

[10] Lau DTY(2001)Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins Metabolism 50 112-66

[1] Hoover-Plow J(2013)Lipoprotein(a) metabolism: potential sites for therapeutic targets Metabolism 62 479-491

[2] Huang M(2018)The identification of Core gene expression signature in hepatocellular carcinoma Oxidative Med Cell Longev 2018 3478305-262

[3] Li N(2018)Management of chronic hepatitis B during pregnancy Gastroenterol Rep (Oxf) 6 257-1067

[4] Li L(2015)Physiology and pathophysiology of liver lipid metabolism Expert Rev Gastroenterol Hepatol 9 1055-2333

[5] Chen Y(2011)Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association Circulation 123 2292-2751

[6] Aslam A(2013)Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans J Clin Invest 123 2742-534

[7] Campoverde Reyes KJ(2003)Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice Arterioscler Thromb Vasc Biol 23 529-359

[8] Malladi VR(2005)The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins Clin Chem 51 351-125

[9] Ishtiaq R(2015)Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease Curr Opin Endocrinol Diabetes Obes 22 119-119

[10] Lau DTY(2001)Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins Metabolism 50 112-66